TuHURA Biosciences
HURA
5 hedge funds and large institutions have $71.9K invested in TuHURA Biosciences in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
38% less funds holding
Funds holding: 8 → 5 (-3)
79% less capital invested
Capital invested by funds: $338K → $71.9K (-$266K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$153K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$32K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$9K |
| 4 |
Renaissance Technologies
New York
|
-$2.79K |
HURA Hedge Fund Activity: Q1 2020 in Review
5 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2020, worth a combined $71.9K — down 79% from $338K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of HURA and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $24.2K. The largest seller was Sabby Management, exiting entirely with an estimated $153K sold.
- 5 institutional investors held TuHURA Biosciences (HURA) as of Q1 2020, down from 8 in Q4 2019.
- Funds reported $71.9K of TuHURA Biosciences stock for Q1 2020, down 79% quarter-over-quarter.
- 2 funds opened new TuHURA Biosciences positions in Q1 2020 and 3 closed out, a net change of -1 holder.
- The largest TuHURA Biosciences buyer in Q1 2020 was Susquehanna International Group, an estimated $24.2K added.
- The largest TuHURA Biosciences seller in Q1 2020 was Sabby Management, an estimated $153K sold.
Based on aggregated 13F filings for Q1 2020.